Table 2 |
|||||
|
Side effects documented in both treatment groups over one month follow up |
|||||
|
Symptom |
Treatment SP N = 120 |
Treatment CQ N = 122 |
Odd's ratio |
95% C1 |
P Value |
|
|
|||||
|
Vomiting Yes No |
8 (6.6%) 112 (93.4%) |
14(11.5%) 108(88.5%) |
0.55 |
0.12 - 1.36 |
0.20 |
|
Blurred vision Yes No |
2 (1.6%) 118(98.4%) |
1(0.8%) 121 (99.2%) |
1.6 |
0.08 - 6.2 |
0.66 |
|
Pruritus Yes No |
2(1.6%) 118(98.4%) |
3(1.8%) 119(98.2%) |
0.6 |
0.07 - 4.67 |
0.32 |
|
Skin rash Yes No |
5 (4.1%) 115 (95.9%) |
3 (1.8%) 119 (98.2%) |
1.74 |
0.38-8.921 |
0.44 |
|
|
|||||
|
Nakibuuka et al. Malaria Journal 2009 8:237 doi:10.1186/1475-2875-8-237 |
|||||